Using admixture mapping, APOL1 has been identified as a risk gene for non-diabetic end-stage renal disease in African Americans [8], [9], [10]; whether this gene is also associated with eGFR is unknown. The gene discussed is APOL1; the disease is stage 5 chronic kidney disease.